Evidence map›Paper›PMID 35315588›Full record

ArticleCancer medicine2022

Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study.

Traci N Bethea, Wanting Zhai, Xingtao Zhou, Tim A Ahles, Jaeil Ahn, Harvey J Cohen, Asma A Dilawari, Deena M A Graham, Heather S L Jim, Brenna C McDonald and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. The impact of the COVID-19 pandemic on breast cancer survivorship: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 1 country.

Traci N BetheaOffice of Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.ORCID 0000-0003-3205-2078
Wanting ZhaiCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Xingtao ZhouCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Tim A AhlesDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York City, USA.
Jaeil AhnDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, District of Columbia, USA.
Harvey J CohenCenter for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina, USA.
Asma A DilawariCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Deena M A GrahamJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Heather S L JimMoffitt Cancer Center, Tampa, Florida, USA.ORCID 0000-0001-7353-3711
Brenna C McDonaldDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
Zev M NakamuraDepartment of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
Sunita K PatelCity of Hope National Medical Center, Los Angeles, California, USA.
Kelly E RentscherCousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, USA.
James RootDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York City, USA.
Andrew J SaykinDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
Brent J SmallCollege of Behavioral and Community Sciences, School of Aging Studies, University of South Florida, Tampa, Florida, USA.
Kathleen M Van DykSemel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA.
Jeanne S MandelblattCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Judith E CarrollCousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, USA.
Georgetown Lombardi Comprehensive Cancer CenterUniversity of California, Los Angeles · USIndiana University Health · USMemorial Sloan Kettering Cancer Center · USCity Of Hope National Medical Center · USDuke University · USGeorgetown University · USHackensack University Medical Center · USMedStar Washington Hospital Center · USMoffitt Cancer Center · USOffice of Minority Health · USUniversity of North Carolina at Chapel Hill · USUniversity of South Florida · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Training and Career Development and Education CoreU54CA137788 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Daniel Alan Heller · 2008 to 2026
$28.1M
Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI CATHLEEN S COLON-EMERIC, Susan Nicole Hastings · 2006 to 2026
$24.6M
Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDREW J SAYKIN · 2021 to 2026
$24.1M
UNC BIRCWH CAREER DEVELOPMENT PROGRAMK12HD001441 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOGGESS, KIM A · 2000 to 2019
$9.3M
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINER01CA129769 · NCI · GEORGETOWN UNIVERSITY · PI AHLES, TIM ALAN, MANDELBLATT, JEANNE · 2009 to 2020
$7.3M
Bio-behavioral Research At The Intersection of Cancer and AgingR35CA197289 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2015 to 2021
$6.2M
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & SmokingR01CA172119 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AHLES, TIM ALAN, HURRIA, ARTI · 2013 to 2017
$3.5M
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled TrialR01CA244673 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FERGUSON, ROBERT J, MCDONALD, BRENNA C · 2020 to 2024
$3.0M
Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive DeclineR01AG068193 · NIA · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE, SAYKIN, ANDREW J · 2020 to 2023
$2.8M
Brain Health in Breast Cancer Survivors: Interaction of Menopause and Endocrine TherapyK08CA241337 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DYK, KATHLEEN · 2019 to 2023
$925k
NCI NIH HHS K01 CA212056NCI NIH HHS K08 CA241337NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA129769NCI NIH HHS R01 CA172119NCI NIH HHS R01 CA244673NCI NIH HHS R35 CA197289NCI NIH HHS U54 CA137788NIA NIH HHS K01 AG065485NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG028716NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG068193NICHD NIH HHS K12 HD001441
6 · The paper itself

Abstract

purposeSeveral studies have reported sleep disturbances during the COVID-19 virus pandemic. Little data exist about the impact of the pandemic on sleep and mental health among older women with breast cancer. We sought to examine whether women with and without breast cancer who experienced new sleep problems during the pandemic had worsening depression and anxiety.

methodsBreast cancer survivors aged ≥60 years with a history of nonmetastatic breast cancer (n = 242) and frequency-matched noncancer controls (n = 158) active in a longitudinal cohort study completed a COVID-19 virus pandemic survey from May to September 2020 (response rate 83%). Incident sleep disturbance was measured using the restless sleep item from the Center for Epidemiological Studies-Depression Scale (CES-D). CES-D score (minus the sleep item) captured depressive symptoms; the State-Anxiety subscale of the State Trait Anxiety Inventory measured anxiety symptoms. Multivariable linear regression models examined how the development of sleep disturbance affected changes in depressive or anxiety symptoms from the most recent prepandemic survey to the pandemic survey, controlling for covariates.

resultsThe prevalence of sleep disturbance during the pandemic was 22.3%, with incident sleep disturbance in 10% and 13.5% of survivors and controls, respectively. Depressive and anxiety symptoms significantly increased during the pandemic among women with incident sleep disturbance (vs. no disturbance) (β = 8.16, p < 0.01 and β = 6.14, p < 0.01, respectively), but there were no survivor-control differences in the effect.

conclusionDevelopment of sleep disturbances during the COVID-19 virus pandemic may negatively affect older women's mental health, but breast cancer survivors diagnosed with the nonmetastatic disease had similar experiences as women without cancer.

Indexed as

Breast NeoplasmsCOVID-19Sleep Wake DisordersAgedAnxietyDepressionFemaleHumansLongitudinal StudiesPandemicsSARS-CoV-2Sleepbehavioral sciencebreast cancerepidemiologypsychosocial studies

Identifiers

PMID35315588
PMCPMC9110906
OpenAlexW4220679956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.